Reactivation of retinopathy of prematurity three years after treatment with bevacizumab

Amir R. Hajrasouliha, Jose M. Garcia-Gonzales, Michael J. Shapiro, Hawke Yoon, Michael P. Blair

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume48
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Fingerprint

Retinopathy of Prematurity
Retinal Detachment
Intravitreal Injections
Laser Therapy
Therapeutics
Vascular Endothelial Growth Factor A
Retina
Recurrence
Bevacizumab

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this

Reactivation of retinopathy of prematurity three years after treatment with bevacizumab. / Hajrasouliha, Amir R.; Garcia-Gonzales, Jose M.; Shapiro, Michael J.; Yoon, Hawke; Blair, Michael P.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 48, No. 3, 01.03.2017, p. 255-259.

Research output: Contribution to journalArticle

Hajrasouliha, Amir R. ; Garcia-Gonzales, Jose M. ; Shapiro, Michael J. ; Yoon, Hawke ; Blair, Michael P. / Reactivation of retinopathy of prematurity three years after treatment with bevacizumab. In: Ophthalmic Surgery Lasers and Imaging Retina. 2017 ; Vol. 48, No. 3. pp. 255-259.
@article{4d6613ae22264fe7acfc18bc4bae72e0,
title = "Reactivation of retinopathy of prematurity three years after treatment with bevacizumab",
abstract = "Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences.",
author = "Hajrasouliha, {Amir R.} and Garcia-Gonzales, {Jose M.} and Shapiro, {Michael J.} and Hawke Yoon and Blair, {Michael P.}",
year = "2017",
month = "3",
day = "1",
doi = "10.3928/23258160-20170301-10",
language = "English (US)",
volume = "48",
pages = "255--259",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "3",

}

TY - JOUR

T1 - Reactivation of retinopathy of prematurity three years after treatment with bevacizumab

AU - Hajrasouliha, Amir R.

AU - Garcia-Gonzales, Jose M.

AU - Shapiro, Michael J.

AU - Yoon, Hawke

AU - Blair, Michael P.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences.

AB - Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences.

UR - http://www.scopus.com/inward/record.url?scp=85017033476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017033476&partnerID=8YFLogxK

U2 - 10.3928/23258160-20170301-10

DO - 10.3928/23258160-20170301-10

M3 - Article

C2 - 28297039

AN - SCOPUS:85017033476

VL - 48

SP - 255

EP - 259

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 3

ER -